Os TherapiesOSTX

13F holders, Q4 2024 (December 31)
5holders −2
2new positions
4sold out
1famous investor
$4.28avg. 13F price*

At the end of Q4 2024, 5 institutions reported holding Os Therapies Inc. (OSTX) in their 13F filings, down 2 from Q3 2024. 2 opened new positions and 4 sold out. The largest holders were CM Management, LLC ($471K), Millennium Management ($128K) and BlackRock, Inc. ($13K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).

Company
Os Therapies Inc.
CUSIP
68764Y207
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 6Q1 2025Q2 2025: 13Q2 2025Q3 2025: 25Q3 2025Q4 2025: 25Q4 2025Q1 2026: 29Q1 2026Q2 2026: 29Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions2$22K
Exits4$138K

All 13F filers, Q3 2024 → Q4 2024: 65,068 shares bought and 80,107 shares sold, net −15,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 5 holders

CM Management, LLC 0.42% Add +120.1% 110,044 $471K
Millennium Management 0.00% Reduce -50.6% 29,836 $128K
BlackRock, Inc. 0.00% New 3,143 $13K
Morgan Stanley 0.00% New 1,881 $8K
Armstrong Advisory Group, Inc. 0.00% No change 100 $428

"% of holder's portfolio" is OSTX's weight in each manager's 13F, not the share of Os Therapies Inc. the manager owns.